ProHEALTH Care Associates, LLP
Lake Success, New York, United States
Neurologist in Lake Success, New York
3/4 Delaware Dr, New Hyde Park, NY 11042
About ProHEALTH Care Associates, LLP
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Genentech, Inc.
2
Novartis Pharmaceuticals
2
Pfizer
2
C. R. Bard
1
CDx Diagnostics
1
Celldex Therapeutics
1
MacroGenics
1
Puma Biotechnology, Inc.
1
US Endoscopy Group Inc.
1
Clinical Trials at ProHEALTH Care Associates, LLP
During the past decade, ProHEALTH Care Associates, LLP conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 10 clinical trials were completed, i.e. on
average, 333.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
2009-06-03
2014-12-04
Completed
724
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis
2010-12-01
2016-01-01
Completed
275
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
2012-04-01
2015-04-01
Terminated
97
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer
2013-02-06
2015-12-10
Completed
183
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ProHEALTH Care Associates, LLP" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "C. R. Bard"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ProHEALTH Care Associates, LLP"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at ProHEALTH Care Associates, LLP
According to Clinical.Site data, the most researched conditions in "ProHEALTH Care Associates, LLP" are
"Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Barrett Esophagus" (2 trials), "Esophageal Dysplasia" (2 trials) and "Advanced Breast Cancer (Female)" (1 trials). Many other conditions were trialed in "ProHEALTH Care Associates, LLP" in a lesser frequency.
Clinical Trials Intervention Types at ProHEALTH Care Associates, LLP
Most popular intervention types in "ProHEALTH Care Associates, LLP" are "Drug" (13 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Trastuzumab" (5 trials), "Pertuzumab" (4 trials), "Placebo" (4 trials), "Docetaxel" (3 trials) and "Fulvestrant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ProHEALTH Care Associates, LLP
The vast majority of trials in "ProHEALTH Care Associates, LLP" are
9 trials for "All" genders and 7 trials for "Female" genders.
Clinical Trials Status at ProHEALTH Care Associates, LLP
Currently, there are NaN active trials in "ProHEALTH Care Associates, LLP".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in ProHEALTH Care Associates, LLP,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ProHEALTH Care Associates, LLP, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".